title: Changes in resting energy expenditure (REE) as a function of tumor response to sunitinib in a cachexic patient with a metastatic endocrine tumor of the pancreas.
authors.forename: Yasmina
authors.initials: Y
authors.lastname: Zoheir
authors.forename: Catherine
authors.initials: C
authors.lastname: Leroux
authors.forename: Denis
authors.initials: D
authors.lastname: Picot
authors.forename: Eveline
authors.initials: E
authors.lastname: Boucher
authors.forename: Odile
authors.initials: O
authors.lastname: Audrain
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Raoul
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002100:Cachexia / Q000209:etiology / Q000378:metabolism*; D002153:Calorimetry, Indirect; D004435:Eating; D004734:Energy Metabolism / Q000187:drug effects*; D006498:Hepatectomy / Q000379:methods; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000556:secondary / Q000601:surgery; D008297:Male; D008875:Middle Aged; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology*; D011758:Pyrroles / Q000627:therapeutic use*; D012146:Rest; D013156:Splenectomy; D000077210:Sunitinib; D016896:Treatment Outcome; D015431:Weight Loss
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib